

Dr. Luis Chiva de Agustín stands as a distinguished figure in the realm of gynecology and obstetrics, serving as a reputable gynecologist with a wealth of experience at Clínica Universidad de Navarra in Pamplona, Spain. With an impressive career spanning 23 years, Dr. Chiva de Agustín specializes in reproductive medicine, earning acclaim for his expertise in the treatment of ovarian cancer and polycystic ovarian syndrome. Beyond his clinical practice, he has notably contributed to research areas such as infertility treatment without embryo manipulation, surgery for advanced ovarian cancer, hereditary female cancer, fertility preservation in female cancers, and teaching models in surgical anatomy for gynecologists. Dr. Chiva de Agustín's educational background includes a degree and a doctorate in Medicine and Surgery from the Universidad Autónoma de Madrid, with specialized training in Gynecology at the Hospital La Paz in Madrid. His extensive professional journey includes a fellowship in Gynecologic Oncology at Rush Presbyterian St. Luke’s Medical Center in Chicago and leadership roles at MD Anderson Center in Madrid. As an educator, he has held positions at various prestigious institutions, including the Complutense University of Madrid, the University of Texas, and the Francisco de Vitoria University. Additionally, Dr. Chiva de Agustín is recognized as a distinguished researcher, contributing to numerous publications and holding memberships in esteemed scientific committees, including the American Society of Gynecologic Oncology and the European Society of Gynecologic Oncology. His commitment to advancing the field is evident through his editorial role at the "Gynecologic Oncology: a multidisciplinary approach" journal and his extensive engagement in research activities, conferences, and congresses.
Dr. Luis Chiva de Agustín is internationally regarded as a leading authority in gynecologic oncology, combining advanced surgical expertise with cutting-edge research and academic leadership. His clinical focus integrates precision oncology, fertility preservation, and innovative surgical education, particularly in complex ovarian cancer management. Through decades of clinical excellence, influential research, and global academic engagement, he continues to shape modern standards in gynecology and women’s cancer care.